NCI virologist Chris Buck bypassed federal red tape by home-brewing a beer vaccine against cancer-linked viruses, handing everyday Americans the recipe to fight Big Pharma’s needle monopoly.
Story Highlights
- Chris Buck engineered yeast in Lithuanian farmhouse ale to produce oral vaccine particles targeting BK polyomavirus, which threatens kidney, bladder, brain, and cancer risks in transplant patients.
- Buck tested on mice, then drank it himself, his brother, and family—reporting strong antibodies without side effects, all outside NCI oversight via his nonprofit.
- Full recipe and data posted publicly on Zenodo.org, empowering DIY biohackers to brew their own amid unpeer-reviewed controversy.
- Promises cheap, needle-free vaccines bypassing government bureaucracy, aligning with President Trump’s push for innovation over regulation.
Buck’s Breakthrough Against Polyomavirus
Virologist Chris Buck at the National Cancer Institute spent over 15 years developing vaccines against BK polyomavirus. This virus infects most people without symptoms but reactivates in immunocompromised patients, causing kidney failure, bladder damage, brain disease, and links to cancers. Buck’s NCI team created injectable versions using VP1 protein, tested in animals including rhesus monkeys in India. Yeast like Saccharomyces cerevisiae, used in brewing and HPV vaccines, served as the platform. Live yeast in beer survived stomach acid, triggering gut immunity in mice after earlier oral failures.
Homebrewing Sidesteps NCI Ethics Blocks
Buck, an avid homebrewer, shifted production to his nonprofit Gusteau Research Corporation to avoid NCI ethics denials for human self-testing. In late May 2025, he drank the first batch—one pint daily for five days. Seven weeks later, he completed two booster rounds. His brother Andrew and family joined, providing finger-prick blood tests showing antibody rises against BK subtypes II and IV at levels Buck claims protect transplant patients. No adverse effects reported. Vilnius University aided yeast engineering.
Public Recipe Challenges Pharma Model
On December 17, 2025, the Buck brothers uploaded methods, data, and the full Lithuanian-style farmhouse ale recipe to Zenodo.org, announced on Buck’s Substack “Viruses Must Die.” Not peer-reviewed, it invites public replication. At the 2026 World Vaccine Congress in Washington, Buck called mouse results “an earthquake” and pledged availability for anyone. This DIY approach democratizes vaccines, cutting costs and needles—echoing conservative values of individual liberty over government-controlled pharma monopolies.
Expert Praise Meets Regulatory Concerns
Immunologist Bryce Chackerian of the University of New Mexico hailed yeast’s potential to deliver proteins to the gut, extending beyond polyomaviruses. Supporters see it reassuring vaccine skeptics with accessible, fun delivery while challenging purified vaccine models. Critics flag small human sample sizes, lack of large trials, and unproven disease protection duration. Beer industry worries about reputation risks. No FDA approval or new trials as of March 2026; Buck plans more self-experiments. This embodies American ingenuity against overregulation.
Sources:
Scientist who homebrewed a beer vaccine (The Times)
New vaccine administered by cold glass of beer (Unilad)
He made beer that’s also a vaccine. Now controversy is brewing (Science News)
The vaccine beer experiment (Promega Connections)
Vaccines yeast beer experiment (Futurism)
This Cancer Researcher Home-Brewed a Beer That Works as a Vaccine (Reason.com)
This scientist brewed and drank his own vaccine beer (Smithsonian)
